These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36993994)

  • 1. Meta-analysis and systematic review of coronary vasospasm in ANOCA patients: Prevalence, clinical features and prognosis.
    Woudstra J; Vink CEM; Schipaanboord DJM; Eringa EC; den Ruijter HM; Feenstra RGT; Boerhout CKM; Beijk MAM; de Waard GA; Ong P; Seitz A; Sechtem U; Piek JJ; van de Hoef TP; Appelman Y
    Front Cardiovasc Med; 2023; 10():1129159. PubMed ID: 36993994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasomotor dysfunction in patients with angina and nonobstructive coronary artery disease is dominated by vasospasm.
    Konst RE; Damman P; Pellegrini D; Hartzema-Meijer MJ; van Uden BJC; Jansen TPJ; Brandsma J; Vart P; Gehlmann H; Maas AHEM; van Royen N; Elias-Smale SE
    Int J Cardiol; 2021 Jun; 333():14-20. PubMed ID: 33711394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic characterisation of different endotypes in coronary artery vasospasm in reaction to acetylcholine.
    Feenstra RGT; Boerhout CKM; Vink CEM; Woudstra J; Wittekoek ME; de Waard GA; Appelman Y; Eringa EC; Marques KMJ; de Winter RJ; van de Hoef TP; Beijk MAM; Piek JJ
    Int J Cardiol Heart Vasc; 2022 Oct; 42():101105. PubMed ID: 36017267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Diltiazem to Improve Coronary Vasomotor Dysfunction in ANOCA: The EDIT-CMD Randomized Clinical Trial.
    Jansen TPJ; Konst RE; de Vos A; Paradies V; Teerenstra S; van den Oord SCH; Dimitriu-Leen A; Maas AHEM; Smits PC; Damman P; van Royen N; Elias-Smale SE
    JACC Cardiovasc Imaging; 2022 Aug; 15(8):1473-1484. PubMed ID: 35466050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary artery spasm and impaired myocardial perfusion in patients with ANOCA: Predictors from a multimodality study using stress CMR and acetylcholine testing.
    Pirozzolo G; Martínez Pereyra V; Hubert A; Guenther F; Sechtem U; Bekeredjian R; Mahrholdt H; Ong P; Seitz A
    Int J Cardiol; 2021 Nov; 343():5-11. PubMed ID: 34499976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex Differences in Coronary Function Test Results in Patient With Angina and Nonobstructive Disease.
    Jansen TPJ; Elias-Smale SE; van den Oord S; Gehlmann H; Dimitiriu-Leen A; Maas AHEM; Konst RE; van Royen N; Damman P
    Front Cardiovasc Med; 2021; 8():750071. PubMed ID: 34722680
    [No Abstract]   [Full Text] [Related]  

  • 7. Sex Difference in Coronary Artery Spasm Tested by Intracoronary Acetylcholine Provocation Test in Patients with Nonobstructive Coronary Artery Disease.
    Park JY; Choi SY; Rha SW; Choi BG; Noh YK; Kim YH
    J Interv Cardiol; 2022; 2022():5289776. PubMed ID: 36131847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvascular coronary artery spasm presents distinctive clinical features with endothelial dysfunction as nonobstructive coronary artery disease.
    Ohba K; Sugiyama S; Sumida H; Nozaki T; Matsubara J; Matsuzawa Y; Konishi M; Akiyama E; Kurokawa H; Maeda H; Sugamura K; Nagayoshi Y; Morihisa K; Sakamoto K; Tsujita K; Yamamoto E; Yamamuro M; Kojima S; Kaikita K; Tayama S; Hokimoto S; Matsui K; Sakamoto T; Ogawa H
    J Am Heart Assoc; 2012 Oct; 1(5):e002485. PubMed ID: 23316292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration.
    Feenstra RGT; van de Hoef TP; Beijk MAM; Piek JJ
    J Vis Exp; 2022 Apr; (182):. PubMed ID: 35435907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on coronary artery spasm 2022 - A narrative review.
    Seitz A; Martínez Pereyra V; Sechtem U; Ong P
    Int J Cardiol; 2022 Jul; 359():1-6. PubMed ID: 35429510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, angiographic and echocardiographic correlates of epicardial and microvascular spasm in patients with myocardial ischaemia and non-obstructive coronary arteries.
    Montone RA; Niccoli G; Russo M; Giaccari M; Del Buono MG; Meucci MC; Gurgoglione F; Vergallo R; D'Amario D; Buffon A; Leone AM; Burzotta F; Aurigemma C; Trani C; Liuzzo G; Lanza GA; Crea F
    Clin Res Cardiol; 2020 Apr; 109(4):435-443. PubMed ID: 31270616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries.
    Ong P; Athanasiadis A; Borgulya G; Vokshi I; Bastiaenen R; Kubik S; Hill S; Schäufele T; Mahrholdt H; Kaski JC; Sechtem U
    Circulation; 2014 Apr; 129(17):1723-30. PubMed ID: 24573349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Management of ANOCA, Part 1-Definition, Patient Population, and Diagnosis: JACC State-of-the-Art Review.
    Samuels BA; Shah SM; Widmer RJ; Kobayashi Y; Miner SES; Taqueti VR; Jeremias A; Albadri A; Blair JA; Kearney KE; Wei J; Park K; Barseghian El-Farra A; Holoshitz N; Janaszek KB; Kesarwani M; Lerman A; Prasad M; Quesada O; Reynolds HR; Savage MP; Smilowitz NR; Sutton NR; Sweeny JM; Toleva O; Henry TD; Moses JW; Fearon WF; Tremmel JA;
    J Am Coll Cardiol; 2023 Sep; 82(12):1245-1263. PubMed ID: 37704315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylcholine-induced coronary spasm in patients with unobstructed coronary arteries is associated with elevated concentrations of soluble CD40 ligand and high-sensitivity C-reactive protein.
    Ong P; Carro A; Athanasiadis A; Borgulya G; Schäufele T; Ratge D; Gaze D; Sechtem U; Kaski JC
    Coron Artery Dis; 2015 Mar; 26(2):126-32. PubMed ID: 25405929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epicardial atherosclerosis and coronary tortuosity in patients with acetylcholine-induced coronary spasm.
    McChord J; Gollwitzer R; Seitz A; Sechtem U; Bekeredjian R; Ong P
    Coron Artery Dis; 2023 Jan; 34(1):34-41. PubMed ID: 36484218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and implications of intracoronary hemodynamic assessment during coronary spasm provocation testing.
    Seitz A; Martínez Pereyra V; Froebel S; Hubert A; McChord J; Bekeredjian R; Sechtem U; Ong P
    Clin Res Cardiol; 2023 Sep; 112(9):1312-1321. PubMed ID: 37195455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Coronary Microvascular Disease and Coronary Vasospasm in Patients With Nonobstructive Coronary Artery Disease: Systematic Review and Meta-Analysis.
    Mileva N; Nagumo S; Mizukami T; Sonck J; Berry C; Gallinoro E; Monizzi G; Candreva A; Munhoz D; Vassilev D; Penicka M; Barbato E; De Bruyne B; Collet C
    J Am Heart Assoc; 2022 Apr; 11(7):e023207. PubMed ID: 35301851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epicardial Coronary Spasm in Women With Angina Pectoris and Unobstructed Coronary Arteries Is Linked With a Positive Family History: An Observational Study.
    Ong P; Pirozzolo G; Athanasiadis A; Sechtem U
    Clin Ther; 2018 Sep; 40(9):1584-1590. PubMed ID: 30122309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Coronary Vasomotor Disorders in Patients With Angina and Nonobstructive Coronary Arteries: A Sydney Experience.
    Rehan R; Wong CCY; Cooke C; Weaver J; Jain P; Adams M; Ng MKC; Yong ASC
    Heart Lung Circ; 2024 Jun; ():. PubMed ID: 38925996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina.
    Sun H; Mohri M; Shimokawa H; Usui M; Urakami L; Takeshita A
    J Am Coll Cardiol; 2002 Mar; 39(5):847-51. PubMed ID: 11869851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.